AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Oncorus to Present at Upcoming Healthcare Investor Conferences

May 16, 2019

CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 16, 2019--

Oncorus, Inc., an oncolytic virus therapeutics company focused on driving innovation to transform outcomes for cancer patients, today announced that its President and Chief Executive Officer, Ted Ashburn, M.D., Ph.D., will provide a company overview and pipeline update at the following upcoming healthcare investor conferences in New York City:

About Oncorus

At Oncorus, we are driving innovation to deliver next-generation, best-in-class oncolytic virus therapies to transform outcomes for cancer patients. We are advancing a portfolio of locally and systemically administered oncolytic virus therapies for a broad spectrum of indications with significant unmet needs based on our oncolytic herpes simplex virus and synthetic oncolytic virus platforms. Our team has engineered proprietary, multidimensional innovations into both platforms to enable us to deliver on the full potential of oncolytic virus therapies to dramatically improve outcomes for cancer patients. Please visit www.oncorus.com to learn more.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190516005307/en/

CONTACT: Media Contact:

Liz Melone

liz@scientpr.com

617-256-6622

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: HEALTH ONCOLOGY GENERAL HEALTH

SOURCE: Oncorus, Inc.

Copyright Business Wire 2019.

PUB: 05/16/2019 07:00 AM/DISC: 05/16/2019 07:00 AM

http://www.businesswire.com/news/home/20190516005307/en

All contents © copyright 2019 The Associated Press. All rights reserved.